A synthetic peptide selectively kills only virulent Paracoccidioides brasiliensis yeasts

Erika Seki Kioshima1, Fabiana Aliperti, Juliana Terzi Maricato

  • 1Department of Microbiology, Immunology and Parasitology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Microbes and Infection
|November 13, 2010
PubMed

Insights

Researchers identified p04 as a biomarker for Paracoccidioides brasiliensis (Pb) virulence. This peptide effectively targets and inhibits virulent fungal strains, offering potential for new Paracoccidioidomycosis (PCM) treatments.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • Paracoccidioides brasiliensis (Pb) causes Paracoccidioidomycosis (PCM), a significant endemic disease in Latin America.
  • Identifying virulence factors is crucial for developing effective therapeutic strategies against Pb.

Purpose of the Study:

  • To identify and characterize novel virulence biomarkers for Paracoccidioides brasiliensis.
  • To evaluate the therapeutic potential of identified biomarkers against Pb infection.

Main Methods:

  • Utilized phage display methodology to select specific binding phages against virulent Pb isolates.
  • In vitro and in vivo assays were performed to assess the efficacy of the derived peptide (pep04).
  • Confocal microscopy was employed to study peptide internalization.

Main Results:

  • Phage display identified p04 phage that specifically binds to virulent Pb strains.
  • The derived peptide, pep04, demonstrated selective killing of virulent Pb in vitro and blocked infection establishment in vivo.
  • Treatment with pep04 significantly reduced lung fungal burden in infected mice.

Conclusions:

  • p04 is established as a reliable biomarker for Pb virulence.
  • Engineered p04 holds promise as an adjuvant therapy for Paracoccidioidomycosis.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...